Astellas Pharma

Astellas Pharma Inc.
TypePublic (K.K)
IndustryPharmaceutical
PredecessorsYamanouchi Pharmaceutical
Fujisawa Pharmaceutical
(Merged in 2005)
Founded1 April 2005 (2005-04-01)
Headquarters2-5-1, Nihonbashi-Honcho, Chūō-ku, Tokyo 103-8411, Japan
Key peopleNaoki Okamura
(President and CEO)
Kenji Yasukawa
(Chairman of the Board)
Products
RevenueIncrease US$11.418 billion  (2023)
Decrease US$1 billion  (2023)
Decrease US$0.742 billion  (2023)
Total assetsDecrease US$18.47 billion  (2023)
Total equityDecrease US$11.33 billion  (2023)
Number of employees
Decrease 14,484 (2023)
SubsidiariesAstellas US
Websitewww.astellas.com/en/
Footnotes
Astellas Pharma office in Canada

Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd. (藤沢薬品工業株式会社, Fujisawa Yakuhin Kōgyō Kabushiki-gaisha).

Astellas is a member of the Mitsubishi UFJ Financial Group (MUFJ) keiretsu.